Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 7/3/2025Vaccine Sales Collapse in China as MNCs Struggle with Local Competitio...
  • 7/3/2025AbbVie's Venclexta Approved in China for Second-Line Treatment of del1...
  • 7/3/2025Eli Lilly's Tirzepatide Approved in China for Treatment of Obstructive...
  • 7/3/2025Hengrui Medicine Gains NMPA Approval for Novel Dry Eye Treatment SHR80...
  • 7/3/2025CTTQ's Homegrown rFVIIa Wins NMPA Approval for Bleeding Disorders
  • 7/3/2025Belief BioMed Unveils 4-Year Follow-Up Data for Hemophilia B Gene Ther...
  • 7/3/2025Cloudbreak Pharma Debuts on HKEX, Raising HK$612 Million in IPO
  • 7/3/2025Akeso Launches Clinical Trials for First Bispecific ADC
  • 7/3/2025Dizal's Lung Cancer Pill Gains FDA Nod, Challenging Rivals in EGFR Exo...
  • 7/3/2025CStone Expands Pipeline with Novel BsAb Targeting Autoimmune and Infla...
  • 7/2/2025API China 2025 Ends with High Attendance and Global Industry Participa...
  • 7/2/2025China to Eliminate CD Submission Requirement for Clinical Trial Databa...
  • 7/2/2025China Issues Technical Guidance for Clinical Resistance Studies of Ant...
  • 7/2/2025HanchorBio and Henlius Ink Major Licensing Deal for I/O Candidate HCB1...
  • 7/2/2025InventisBio Launches First Phase III Trial of TYK2 Inhibitor D‑2570 i...
  • 7/2/2025Betta's Tibremciclib Approved in China for Advanced HR+/HER2– Breast ...
  • 7/2/2025NMPA Grants Marketing Approval to GeneScience's Firsekibart for Acute ...
  • 7/2/2025China Grants Conditional Approval to Bebetter Medicine's Ifupinostat f...
  • 7/2/2025Simcere's Suvemcitug Approved in China for Platinum-Resistant Ovarian ...
  • 7/2/2025Biokin's Iza-bren Achieves Primary Endpoint in Phase III Trial for Nas...
  • 7/1/2025Record China Pharma Monopoly Fine Sends Strong Deterrent Signal, Exper...
  • 7/1/2025Jinhua Conba and EVA Forge Strategic Partnership to Strengthen China-M...
  • 7/1/2025China's STAR Market Approves Heyuan Biotech's IPO
  • 7/1/2025China Launches New Tax Incentives to Boost Foreign Companies' Reinvest...
  • 7/1/2025​​​​​​​Zai Lab-Backed FORTITUDE-101 Trial Hits Key Milestone in...
  • 7/1/2025Revolution Medicines and Summit Therapeutics Launch RAS-Targeting Comb...
  • 7/1/2025Hengrui's Ivarmacitinib Approved in China for Severe Alopecia Areata
  • 7/1/2025Adagene Secures Up to $25 Million from Sanofi to Advance SAFEbody Pipe...
  • 7/1/2025Healthgen Biotech IPO Approved, First STAR Market Biopharma Case Since...
  • 7/1/2025NHSA Seeks Public Input on 2025 Drug Reimbursement and Innovation List...
  • Page:1/53 Total number of articles:1570: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group